Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience
- Marc R. Matrana
- , Tharakeswara Bathala
- , Matthew T. Campbell
- , Cihan Duran
- , Aditya Shetty
- , Purnima Teegavarapu
- , Sarathi Kalra
- , Lianchun Xiao
- , Bradley Atkinson
- , Paul Corn
- , Eric Jonasch
- , Nizar M. Tannir
Research output: Contribution to journal › Article › peer-review
19
!!Link opens in a new tab
Scopus
citations